FARKUF-AM
January 14, 2025
FARKUF- DX
January 14, 2025
FARKUF- BR
Bromhexine I.P. 2 mg + Terbutaline I.P. 1.25 mg + Guaiphenesin I.P. 50 mg & Menthol 0.5 mg
Product Description
FARKUF-BR Syrup is a combination respiratory formulation designed to provide relief from productive cough and chest congestion. It contains Bromhexine I.P. (2 mg), Terbutaline I.P. (1.25 mg), Guaiphenesin I.P. (50 mg), and Menthol (0.5 mg).
Bromhexine acts as a mucolytic, helping to thin and loosen mucus in the airways. Guaiphenesin works as an expectorant, facilitating the removal of mucus through coughing. Terbutaline is a bronchodilator that helps open the airways, making breathing easier. Menthol provides a soothing effect on the throat.
This combination ensures effective relief from chest congestion, productive cough, and breathing discomfort.
Key Benefits
- Helps loosen and clear mucus from airways
- Relieves productive (wet) cough
- Eases breathing by opening air passages
- Reduces chest congestion
- Provides soothing relief to the throat
Key Ingredients
- Bromhexine – Mucolytic agent
- Terbutaline – Bronchodilator
- Guaiphenesin – Expectorant
- Menthol – Soothing agent
Indications
- Productive Cough
- Bronchitis
- Chronic Obstructive Pulmonary Disease (COPD)
- Chest congestion
- Respiratory tract infections with mucus
Dosage / Usage
- Take as directed by a physician
- Shake well before use
- Use a measuring cup for accurate dosage
Precautions
- Use under medical supervision
- May cause mild side effects like tremors or palpitations (due to bronchodilator)
- Avoid exceeding recommended dosage
- Use cautiously in patients with heart conditions or hypertension
- Store in a cool, dry place
- Keep out of reach of children
| Packing |
|---|
